Ginkgo Bioworks Holdings Stock Beta
| DNA Stock | USD 0.87 0.04 4.40% |
Ginkgo Bioworks Holdings fundamentals help investors to digest information that contributes to Ginkgo Bioworks' financial success or failures. It also enables traders to predict the movement of Ginkgo Stock. The fundamental analysis module provides a way to measure Ginkgo Bioworks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ginkgo Bioworks stock.
Ginkgo | Beta |
Ginkgo Bioworks Holdings Company Beta Analysis
Ginkgo Bioworks' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Ginkgo Bioworks Beta | 1.36 |
Most of Ginkgo Bioworks' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ginkgo Bioworks Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ginkgo Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Ginkgo Bioworks is extremely important. It helps to project a fair market value of Ginkgo Stock properly, considering its historical fundamentals such as Beta. Since Ginkgo Bioworks' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ginkgo Bioworks' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ginkgo Bioworks' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Ginkgo Bioworks Holdings has a Beta of 1.357. This is 57.79% higher than that of the Biotechnology sector and 2.37% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Ginkgo Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ginkgo Bioworks' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics of similar companies.Ginkgo Bioworks is currently under evaluation in beta category among related companies.
Ginkgo Bioworks Institutional Holders
Institutional Holdings refers to the ownership stake in Ginkgo Bioworks that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ginkgo Bioworks' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ginkgo Bioworks' value.| Shares | Geode Capital Management, Llc | 2023-12-31 | 21.1 M | Norges Bank | 2023-12-31 | 14.8 M | Millennium Management Llc | 2023-12-31 | 9.3 M | Exor Investments (uk) Llp | 2023-12-31 | 8.5 M | Charles Schwab Investment Management Inc | 2023-12-31 | 7.7 M | Welch & Forbes Llc | 2023-12-31 | 7 M | Northern Trust Corp | 2023-12-31 | 6.1 M | Citadel Advisors Llc | 2023-09-30 | 5.2 M | Susquehanna International Group, Llp | 2023-12-31 | 4.9 M | Baillie Gifford & Co Limited. | 2023-12-31 | 236.3 M | Ark Investment Management Llc | 2023-12-31 | 198.6 M |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ginkgo Bioworks will likely underperform.
Ginkgo Fundamentals
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (5.16) % | ||||
| Current Valuation | 1.15 B | ||||
| Shares Outstanding | 1.65 B | ||||
| Shares Owned By Insiders | 6.70 % | ||||
| Shares Owned By Institutions | 83.99 % | ||||
| Number Of Shares Shorted | 270.83 M | ||||
| Price To Earning | 25.51 X | ||||
| Price To Book | 1.98 X | ||||
| Price To Sales | 8.65 X | ||||
| Revenue | 251.46 M | ||||
| Gross Profit | 273.49 M | ||||
| EBITDA | (600.68 M) | ||||
| Net Income | (892.87 M) | ||||
| Cash And Equivalents | 1.32 B | ||||
| Cash Per Share | 0.84 X | ||||
| Total Debt | 241.77 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 11.84 X | ||||
| Book Value Per Share | 0.55 X | ||||
| Cash Flow From Operations | (295.5 M) | ||||
| Short Ratio | 11.02 X | ||||
| Earnings Per Share | (0.46) X | ||||
| Target Price | 1.92 | ||||
| Number Of Employees | 1.22 K | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 1.99 B | ||||
| Total Asset | 1.67 B | ||||
| Retained Earnings | (5.29 B) | ||||
| Working Capital | 837.89 M | ||||
| Current Asset | 10.07 B | ||||
| Current Liabilities | 3.1 B | ||||
| Net Asset | 1.67 B |
About Ginkgo Bioworks Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ginkgo Bioworks Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Ginkgo Bioworks
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ginkgo Bioworks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will appreciate offsetting losses from the drop in the long position's value.Moving against Ginkgo Stock
| 0.58 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.52 | MRKR | Marker Therapeutics | PairCorr |
The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.
The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ginkgo Bioworks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Ginkgo Bioworks Piotroski F Score and Ginkgo Bioworks Altman Z Score analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.129 | Quarterly Revenue Growth (0.65) | Return On Assets (0.22) | Return On Equity (0.63) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.